Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Applying for Breakthrough seems very close now

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon May 10, 2023 2:46pm

143 Views

Post# 35441377

RE:RE:RE:Applying for Breakthrough seems very close now

Rumpl3StiltSkin wrote: According to the table 1 from the NR there are 5 IR patients left to evaluate 6 months from now. I don't think TLT will be waiting that long to apply for BTD just to determine where those 5 patients are.... My guess is they have recently applied for BTD. They have the numbers NOW for that and have for some time. IMO

They have 37 patients at 450 days, heck they can even apply for AA. No need to wait to confirm those IR patients IMO

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?